
GALT
USDGalectin Therapeutics Inc. Common Stock
$5.670-0.310 (-5.184%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$5.980
High
$6.250
Low
$5.550
Volume
0.50M
Company Fundamentals
Market Cap
365.6M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.31M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.73Current $5.670High $6.55
Related News
Analyst Upgrades
HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $6 Price Target
HC Wainwright & Co. analyst Matthew Keller reiterates Galectin Therapeutics with a Buy and maintains $6 price target.
View more
Related Stocks
CXE
MFS High Income Municipal Trust
NASDAQ
Investment Mana...
NXDT
NexPoint Diversified Real Estate Trust
NASDAQ
Real Estate Inv...
SLN
Silence Therapeutics Plc American Depository Share
NASDAQ
Biotechnology: ...
CMPS
COMPASS Pathways Plc American Depository Shares
NASDAQ
Biotechnology: ...
CHRO
Chromocell Therapeutics Corporation
NASDAQ
Biotechnology: ...
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.